Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 8, 1996, Pages 934-940

  Jong, Miek C ^a   Dahlmans, Vivian E H ^a   Van Gorp, Patrick J J ^b   Breuer, Marco L ^b   Mol, Marc J T M ^c   Van der Zee, André ^b   Frants, Rune R ^b   Hofker, Marten H ^b   Havekes, Louis M ^a  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

apolipoprotein C; apolipoprotein E; hyperlipoproteinemia; transgenic mice

Indexed keywords

APOLIPOPROTEIN C1; APOLIPOPROTEIN E; CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HYPERLIPOPROTEINEMIA; LIPOLYSIS; LIVER CLEARANCE; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029816096     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.8.934     Document Type: Article

References (34)

1. de Knijff P, van den Maagdenberg AMJM, Stalenhoef AFH, Gevers Leuven JA, Demacker PNM, Kuyt LP, Frants RR, Havekes LM. Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree. J Clin Invest. 1991;88:643-655.
2. Wardell MR, Weisgraber KH, Havekes LM, Rail SC Jr. Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121-127. J Biol Chem. 1989;264:21205-21210.
3. van den Maagdenberg AMJM, Hofker MH, Krimpenfort PJA, de Bruijn IH, van Vlijmen BJM, van der Boom H, Havekes LM, Frants RR. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J Biol Chem. 1993;268:10540-10545.
4. van Vlijmen BJM, van den Maagdenberg AMJM, Gijbels MJJ, van der Boom H, Hogenesch H, Frants RR, Hofker MH, Havekes LM. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J Clin Invest. 1994;93:1403-1410.
5. van Vlijmen BJM, van der Boom H, van 't Hof HB, van der Zee A, Frants RR, Hofker MH, Havekes LM. Modulation of VLDL production and clearance contributes to age and gender dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice. J Clin Invest. 1996;97:1184-1192.
6. Simonet WS, Bucay N, Lauer SJ, Taylor JM. A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-1 genes in transgenic mice. J Biol Chem. 1993;268:8221-8229.
7. Havel RJ, Fielding CJ, Olivecrona T, Shore VG, Fielding PE, Egelrud T. Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoprotein lipase from different sources. Biochemistry. 1973;12:1828-1833.
8. Brown V, Baginsky ML. Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochim Biophys Acta. 1972;46:375-382.
9. Windier E, Havel RJ. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. J Lipid Res. 1985;26:556-565.
10. Quarfordt SH, Michalopoulos G, Schirmer B. The effect of human C apolipoproteins on the in vitro hepatic metabolism of triglyceride emulsions in the rat. J Biol Chem. 1982;257:14642-14647.
11. Sehayek E, Eisenberg S. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor. J Biol Chem. 1991;266:18259-18267.
12. Kowal RC, Herz J, Weisgraber KH, Mahley RW, Brown MS, Goldstein JL. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J Biol Chem. 1990;265:10771-10779.
13. Weisgraber KH, Mahley RW, Kowal RC, Herz J, Goldstein JL, Brown MS. Apolipoprotein C-I modulates the interaction of apolipoprotein E with β-migrating very low density lipoproteins (βVLDL) and inhibits binding of β-VLDL to low density lipoprotein receptor-related protein. J Biol Chem. 1990;265:22453-22459.
14. Swaney JB, Weisgraber KH. Effect of apolipoprotein C-l peptides on the apolipoprotein E content and receptor-binding properties of beta-migrating very low density lipoproteins. J Lipid Res. 1994;35:134-142.
15. Simonet WS, Bucay N, Pitas RE, Lauer SJ, Taylor JM. Multiple tissue-specific elements control the apolipoprotein E/C1 gene locus in transgenic mice. J Biol Chem. 1991;266:8651-8654.
16. van Ree JH, Hofker MH, van den Broek WJAA, van Deursen JMA, van der Boom H, Frants RR, Wieringa B, Havekes LM. Increased response to cholesterol feeding in apolipoprotein C-l deficient mice. Biochem J. 1995;305:905-911.
17. Shachter NS, Zhu Y, Walsh A, Breslow JL, Smith JD. Localization of a liver-specific enhancer in the apolipoprotein E/C-I/C-II gene locus. J Lipid Res. 1993;34:1699-1707.
18. Hogan B, Costantini F, Lacey E. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1986.
19. Zannis VI, McPherson J, Goldberger G, Karathanasis SU, Breslow JL. Synthesis, intracellular processing, and signal peptide of human apolipoprotein E. J Biol Chem. 1984;259:5495-5499.
20. Hoffer MJV, van Eck MH, Havekes LM, Hofker MH, Frants RR. The mouse apolipoprotein C1 gene: structure and expression. Genomics. 1993;18:37-42.
21. Fort P, Marty L, Ptechaczyk M, Sabrouty SE, Dani C, Jeanteur P, Blanchard JM. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. NAR. 1985;13:1431-1442.
22. Nishina PM, Verstuyft J, Paigen B. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J Lipid Res. 1990;31:859-869.
23. van Ree JH, van den Broek WJAA, Dahlmans VEH, Groot PHE, Vidgeon-Hart M, Frants RR, Wieringa B, Havekes LM, Hofker MH. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. Atherosclerosis. 1994;111:25-37.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Polin phenol reagent. J Biol Chem. 1951;193:265-275.
25. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-917.
26. Bernstein SE. Physiological characteristics. In: Green EL, ed. Biology of the Laboratory Mouse. 2nd ed. New York, NY: Dover Publications Inc; 1979:337-350.
27. Moir AMB, Zammit VA. Selective labelling of hepatic fatty acids in vivo. Biochem J. 1992;283:145-149.
28. Aalto-Setala K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, Walsh A, Ramakrishnan R, Ginsberg HN, Breslow JL. Mechanism of hypertriglyceridemia in human apolipoprotein (Apo) CIII transgenic mice. J Clin Invest. 1992;90:1889-1900.
29. de Silva HV, Lauer SJ, Wang J, Simonet WS, Weisgraber KH, Mahley RW, Taylor JM. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J Biol Chem. 1994;269:2324-2335.
30. Shachter NS, Hayek T, Leff T, Smith JD, Rosenberg DW, Walsh A, Ramakrishnan R, Goldberg IJ, Ginsberg HN, Breslow JL. Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice. J Clin Invest. 1994;93:1683-1690.
31. Mulder M, van der Boom H, de Knijff P, Braam C, van den Maagdenberg A, Gevers Leuven JA, Havekes LM. Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2 (Lys 146→Gln) are inefficiently converted to cholesterol-rich lipoproteins. Atherosclerosis. 1994;108:183-192.
32. McConathy WJ, Wang C-S. Inhibition of lipoprotein lipase by the receptor-binding domain of apolipoprotein E. FEBS Lett. 1989;251:250-252.
33. Ji Z-S, Fazio S, Mahley RW. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia. J Biol Chem. 1994;269:13421-13428.
34. Clark AB, Quarfordt SH. Apolipoprotein effects on the lipolysis of perfused triglyceride by heparin-immobilized milk lipase. J Biol Chem. 1985;260:4778-4783.